Morgan Stanley’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $132M | Buy |
|
|||||
2025
Q1 | $50.3M | Buy |
|
|||||
2024
Q4 | $44M | Sell |
|
|||||
2024
Q3 | $49.6M | Buy |
|
|||||
2024
Q2 | $45.4M | Sell |
|
|||||
2024
Q1 | $100M | Sell |
|
|||||
2023
Q4 | $215M | Buy |
|
|||||
2023
Q3 | $18.4M | Sell |
|
|||||
2023
Q2 | $24.6M | Sell |
|
|||||
2023
Q1 | $23.9M | Buy |
|
|||||
2022
Q4 | $20.4M | Sell |
|
|||||
2022
Q3 | $101M | Sell |
|
|||||
2022
Q2 | $83.9M | Buy |
|
|||||
2022
Q1 | $14.3M | Buy |
|
|||||
2021
Q4 | $14.9M | Buy |
|
|||||
2021
Q3 | $13.9M | Sell |
|
|||||
2021
Q2 | $47.1M | Buy |
|
|||||
2021
Q1 | $6.03M | Sell |
|
|||||
2020
Q4 | $26.3M | Buy |
|
|||||
2020
Q3 | $6.24M | Sell |
|
|||||
2020
Q2 | $5.93M | Buy |
|
|||||
2020
Q1 | $4.43M | Sell |
|
|||||
2019
Q4 | $9.09M | Buy |
|
|||||
2019
Q3 | $3.42M | Sell |
|
|||||
2019
Q2 | $5.29M | Buy |
|
|||||
2019
Q1 | $3.02M | Sell |
|
|||||
2018
Q4 | $13M | Buy |
|
|||||
2018
Q3 | $9.09M | Sell |
|
|||||
2018
Q2 | $23.7M | Buy |
|
|||||
2018
Q1 | $17.2M | Sell |
|
|||||
2017
Q4 | $25.9M | Buy |
|
|||||
2017
Q3 | $4.18M | Buy |
|
|||||
2017
Q2 | $2.43M | Sell |
|
|||||
2017
Q1 | $3.59M | Sell |
|
|||||
2016
Q4 | $2.65M | Buy |
|
|||||
2016
Q3 | $279K | Sell |
|
|||||
2016
Q2 | $635K | Buy |
|
|||||
2016
Q1 | $521K | Sell |
|
|||||
2015
Q4 | $809K | Buy |
|
|||||
2015
Q3 | $587K | Buy |
|
|||||
2015
Q2 | $38K | Buy |
|